Zobrazeno 1 - 10
of 223
pro vyhledávání: '"M R Christiaens"'
Publikováno v:
Journal of the Belgian Society of Radiology, Vol 94, Iss 6, Pp 330-332 (2011)
Metastatic extramammary breast tumours are uncommon and differential diagnosis with primary breast carcinoma may prove to be difficult. We report a case of a metastasis of a renal cell cancer in the breast in a woman with a history of primary breast
Externí odkaz:
https://doaj.org/article/db6451086a6143358f69863a0e080d4c
Autor:
Linda R. Duska, Y. Xiang, M Puglisi, Benoit You, M-R Christiaens, A Oaknin, D Lorusso, Robert L. Coleman, J Sehouli, Leslie M Randall, M Mirza, C Marth, Cagatay Taskiran, David Cibula, Sandro Pignata, Angélica Nogueira-Rodrigues, K Yamada, N Colombo, Jacob Korach, Kosei Hasegawa
Publikováno v:
E-Posters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7aace2aaf975725d0273a236c37a4c51
https://doi.org/10.1136/ijgc-2021-igcs.104
https://doi.org/10.1136/ijgc-2021-igcs.104
Autor:
Ignace Vergote, M Tahapary, M-R Christiaens, T Van Gorp, E Van Nieuwenhuysen, R Salihi, Sileny Han, H Toelen, Patrick Neven
Publikováno v:
Quality of life after treatment.
Introduction/Background* Locally advanced cervical cancer can be treated by concomitant chemoradiation therapy (CCRT) followed by brachytherapy or by neo-adjuvant chemotherapy followed by surgery (NACT-S). Quality of life (QoL) and sexual health (SH)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::970afd7c87767f83cacf304a0bdfe2f5
https://doi.org/10.1136/ijgc-2021-esgo.584
https://doi.org/10.1136/ijgc-2021-esgo.584
Autor:
K Yamada, Jacob Korach, Mirza, M-R Christiaens, Cagatay Taskiran, Sandro Pignata, Domenica Lorusso, Christian Marth, Leslie M Randall, N Colombo, Jalid Sehouli, David Cibula, Robert L. Coleman, Angélica Nogueira-Rodrigues, A Oaknin, Benoit You, Linda R. Duska, Y. Xiang, M Puglisi, Kosei Hasegawa
Publikováno v:
Cervical cancer.
Introduction/Background* High-risk locally advanced cervical cancer has a poor prognosis, and more than half of patients recur in 2 years. External beam radiotherapy (EBRT) with concurrent chemotherapy followed by brachytherapy is the standard of car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::748f2b2fb4f6110747a44186546b7628
https://doi.org/10.1136/ijgc-2021-esgo.21
https://doi.org/10.1136/ijgc-2021-esgo.21
Autor:
M Puglisi, Leslie M Randall, Y. Xiang, David Cibula, Nicoletta Colombo, Robert L. Coleman, Kosei Hasegawa, Linda R. Duska, Jalid Sehouli, Stephen Michael Keefe, Christian Marth, Jacob Korach, Ana Oaknin, M-R Christiaens, Angélica Nogueira-Rodrigues, Domenica Lorusso, Benoit You, Cagatay Taskiran, Salvatore Antonio Pignata, Mansoor Raza Mirza
Publikováno v:
Annals of Oncology. 31:S1341-S1342
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::549cd0db5c5b4f4e3d62990d37630efe
https://doi.org/10.1016/j.annonc.2020.10.248
https://doi.org/10.1016/j.annonc.2020.10.248
Autor:
T Van Gorp, E Van Nieuwenhuysen, A-S Van Rompuy, M-R Christiaens, J Haesen, Patrick Neven, Ignace Vergote, R Salihi, Sileny Han
Publikováno v:
ePoster Talks: Cervical Cancer.
Introduction/Background Lymphovascular space invasion (LVSI), deep stromal invasion (DSI) and large tumor size have been identified as predictors for intermediate risk for recurrence. Adjuvant radiotherapy (RT) has been advocated in these patients (S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00c972ed2e98c36f0d18353006f20d03
https://doi.org/10.1136/ijgc-2019-esgo.51
https://doi.org/10.1136/ijgc-2019-esgo.51
Autor:
Karin Leunen, Frédéric Amant, Ines Nevelsteen, Ignace Vergote, E. Van Limbergen, M-R Christiaens, Olivier Brouckaert, Guiseppe Floris, Annouschka Laenen, Caroline Weltens, Stéphanie Peeters, A Poppe, Patrick Berteloot, A Smeets, A. Soubry, H. Wildiers, C Remmerie, Patrick Neven
Publikováno v:
Cancer Research. 76:P6-09
Background: Young women present more often with aggressive breast cancer phenotypes and have worse prognosis. It remains controversial whether age is an independent prognostic factor in early stage breast cancer. Arbitrarily chosen age cut-off values
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84d54e7e4d1352114112452d088450b1
https://doi.org/10.1158/1538-7445.sabcs15-p6-09-11
https://doi.org/10.1158/1538-7445.sabcs15-p6-09-11
Autor:
Patrick Berteloot, H. Wildiers, Patrick Neven, Ignace Vergote, A Smeets, E. Van Limbergen, Annouschka Laenen, Karin Leunen, Caroline Weltens, Frédéric Amant, E Borowski, A Poppe, C Remmerie, Stéphanie Peeters, M-R Christiaens, Ines Nevelsteen, W Poppe, K. Van Asten, Guiseppe Floris
Publikováno v:
Cancer Research. 76:P6-09
OBJECTIVE: The levonorgestrel-intrauterine device (LNG-IUD) is a widely used contraceptive method. It is not clear if LNG-IUD users are more likely to develop breast cancer. Breast cancer growth through the estrogen and/or the human epidermal growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d25eb101b5e1aa2b1c05be33641807d
https://doi.org/10.1158/1538-7445.sabcs15-p6-09-12
https://doi.org/10.1158/1538-7445.sabcs15-p6-09-12
Autor:
Caroline Weltens, Karin Leunen, Frédéric Amant, Annouschka Laenen, A Poppe, Stéphanie Peeters, E. Van Limbergen, Guiseppe Floris, Patrick Neven, Ignace Vergote, Patrick Berteloot, Olivier Brouckaert, M-R Christiaens, H. Wildiers, A Smeets
Publikováno v:
Cancer Research. 76:P6-10
Background Evidence suggests that premenopausal obesity decreases and postmenopausal obesity increases breast cancer risk. While it has been hypothesized that carcinogenesis may be accelerated by a disrupted metabolic homeostasis in obese women, it i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06d1dbd948c6bc236ef49a38ae1a6815
https://doi.org/10.1158/1538-7445.sabcs15-p6-10-06
https://doi.org/10.1158/1538-7445.sabcs15-p6-10-06
Autor:
Herman Depypere, G. Vandeputte, Chantal Blomme, A. S Dieudonne, Christel Fontaine, Vincent O. Dezentjé, Patrick Berteloot, J. Decloedt, M-R Christiaens, H. Wildiers, Anneleen Lintermans, Annouschka Laenen, C Vereecke, Markus Joerger, Patrick Neven, D Lambrechts, B. Van Calster, D. Timmerman, A Poppe
Publikováno v:
Cancer Research. 76:P3-07
Background: Tamoxifen is commonly used for the treatment of all stages of estrogen receptor (ER) positive breast cancer (BC), the largest group of BC. In postmenopausal women, known endometrial side-effects are cystic appearance, hyperplasia, polyps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7119437ecaec783dd3a9bda7b721560
https://doi.org/10.1158/1538-7445.sabcs15-p3-07-46
https://doi.org/10.1158/1538-7445.sabcs15-p3-07-46